# Anthropic's wet lab tests AI biology theories in real experiments

> The AI safety company is running physical biology experiments to validate its models' disease-fighting potential, raising questions about its dual focus on safety and capability.
- Title: Anthropic's wet lab tests AI biology theories in real…
- Summary: The AI safety company is running physical biology experiments to validate its models' disease-fighting potential, raising questions about its dual focus on…
- Keywords: anthropic, ai models, biology experiments, wet lab, drug discovery, life sciences, dario amodei, ai safety, biotech, protein design, pharmaceutical partnerships, novo nordisk
- Source: TechCrunch — https://techcrunch.com/2026/09/18/anthropic-is-operating-a-lab-that-conducts-biology-experiments
- Author: Julie Bort
- Published: 2026-09-18T23:13:31+00:00
- Read time: 1 min
- Topics: anthropic, ai models, biology experiments, wet lab, drug discovery, life sciences, dario amodei, ai safety, biotech, protein design, pharmaceutical partnerships, novo nordisk
## Anthropic runs a real biology lab
The AI company confirmed it operates a wet biology lab in the Bay Area where it uses AI models to conduct physical experiments. The lab works like most biotech facilities, combining internal research with external partnerships.
## AI needs real-world testing for medicine
Anthropic's head of life sciences says the final test for biology work must happen in actual labs. CEO Dario Amodei recently claimed AI could cure most major diseases in five to ten years.

> I believe that AI could cure most major diseases in the next 5, 10 years.
## Anthropic acquired a biotech startup
The company bought Coefficient Bio, a stealth AI biotech firm, in April to build its biology capabilities. This acquisition laid groundwork for the lab's operations.
## Focus is fundamental research, not drugs
Anthropic says its lab focuses on fundamental biology rather than drug discovery to avoid competing with pharmaceutical partners like Novo Nordisk. The company recently announced a joint drug discovery deal with Novo Nordisk.
## New program gives researchers model access
Anthropic launched a Life Sciences Verification Program this week to give vetted biology researchers access to its most powerful AI models. The company also published reports on protein design and biomolecular modeling research.
## Safety warnings clash with expansion
Anthropic researcher Jacob Coxon recently resigned warning AI could kill humanity by decade's end. CEO Dario Amodei called for industry slowdown and self-regulation, yet the company is simultaneously building biotech labs.

> the people building AI earnestly believe that it could kill us all by the end of the decade
## Industry questions the contradiction
Investors and tech leaders have noted the tension between Anthropic's dire safety warnings and its new wet lab. One founder joked the group behind 'We're All Going To Die' is now building biology labs in San Francisco.
## Key takeaway

Anthropic is building real lab infrastructure to test whether AI can actually solve biology problems, not just theorize about them, while navigating tensions between its safety messaging and biotech ambitions.